COMMUNIQUÉS West-GlobeNewswire

Teligent, Inc. Announces Second Quarter 2018 Results

08/08/2018 - 22:15

BUENA, N.J., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the second quarter ended June 30, 2018 [...]

INSYS Therapeutics Reports Second Quarter 2018 Results

08/08/2018 - 22:15

Focus remains on advancing pipeline across cannabinoid and spray platforms PHOENIX, Aug. 08, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the development, manufacture and [...]

Nephros Reports Second Quarter 2018 Financial Results

08/08/2018 - 22:10

Quarterly Product Revenue Up 55% Year-over-Year; Total Revenue Up 59% Company Plans Uplist to National Stock Exchange Conference Call Scheduled for Today, August 8, 2018, at 4:30 PM EDT SOUTH ORANGE, N.J., Aug. 08, 2018 [...]

Scholar Rock Reports Second Quarter 2018 Financial Results and Updates on Business Progress

08/08/2018 - 22:08

Completed Initial Public Offering Raising $86.3 Million in Gross Proceeds Initiated Enrollment in Multiple-Ascending Dose Portion of Phase 1 Clinical Trial for SRK-015 On Track to Initiate Phase 2 Proof-of-Concept Study [...]

Chembio Diagnostics Appoints Dr. Mary Lake Polan to its Board of Directors

08/08/2018 - 22:06

MEDFORD, N.Y., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leader in point-of-care ("POC") diagnostic testing, today announced that Mary Lake Polan, M.D., Ph.D., M.P.H., has been [...]

Achillion Reports Second Quarter 2018 Financial Results

08/08/2018 - 22:05

- Global phase 2 clinical programs for ACH-4471 continue to expand in PNH and C3G - - Completed dosing phase 1 clinical study of ACH-5228 and initiated phase 1 study of ACH-5548 - - June 30, 2018 cash position $295.8 [...]

Zafgen to Present at the Wedbush PacGrow Healthcare Conference

08/08/2018 - 22:05

BOSTON, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq:ZFGN), a clinical-stage biopharmaceutical company leveraging its proprietary knowledge of MetAP2 systems biology to develop novel therapies for patients [...]

aTyr Pharma to Host Conference Call and Webcast of Second Quarter 2018 Financial Results on August 14, 2018

08/08/2018 - 22:05

SAN DIEGO, Aug. 08, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today [...]

BeiGene Announces Closing of Its HK$7.08 billion (US$903 million) Hong Kong Initial Public Offering and Global Offering

08/08/2018 - 22:05

BEIJING, China and CAMBRIDGE, Mass., Aug. 08, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted [...]

AGTC to Present at the Wedbush PacGrow Healthcare Conference on August 15, 2018

08/08/2018 - 22:05

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (NASDAQ: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV [...]

Codexis Reports Second Quarter 2018 Financial Results

08/08/2018 - 22:05

Total revenues increase 31% to $13.5 million driven by higher R&D revenue Phase 1a clinical trial for CDX-6114 initiated Conference call begins at 4:30 p.m. Eastern time today REDWOOD CITY, Calif., Aug. 08, 2018 ( [...]

Wright Medical Group N.V. Reports 2018 Second Quarter Financial Results

08/08/2018 - 22:05

Second Quarter 2018 Net Sales of $205 Million Second Quarter 2018 Net Loss From Continuing Operations of $91 Million; Non-GAAP Adjusted EBITDA From Continuing Operations of $26 Million U.S. Upper Extremities Business [...]

Sonoma Pharmaceuticals Reports First Quarter FY 2019 Financial Results

08/08/2018 - 22:05

Total Revenue up 20 % over March 2018 Quarter Total Revenue up 14% over June 2017 Quarter Conference Call Begins at 4:30pm EDT Today PETALUMA, Calif., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. ( [...]

OraSure Announces 2018 Second Quarter Financial Results

08/08/2018 - 22:05

BETHLEHEM, Pa., Aug. 08, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced its consolidated financial results [...]

OrthoPediatrics Corp. Reports Second Quarter 2018 Financial Results

08/08/2018 - 22:05

Record Revenue of $15.1 Million, Up 27.7% Year-over-Year WARSAW, Ind., Aug. 08, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ:KIDS), a company exclusively focused on advancing the field of pediatric orthopedics [...]

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2018

08/08/2018 - 22:05

Reports Net Revenues of $71.0 Million for the Three Months Ended June 30, 2018 RANCHO CUCAMONGA, Calif., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) (“Amphastar” or the “Company”) [...]

Assure Holdings Corp. Announces Update

08/08/2018 - 22:05

DENVER, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services announces that it expects to file unaudited [...]

Assembly Biosciences Announces Second Quarter 2018 Financial Results

08/08/2018 - 22:05

- ABI-H0731 Phase 2a Clinical Trials Actively Enrolling Patients; Initial Data Continues to be Anticipated in H1 2019 - Strong Balance Sheet Provides Significant Runway SAN FRANCISCO and INDIANAPOLIS, Aug. 08, 2018 ( [...]

Adverum Biotechnologies Reports Second Quarter 2018 Financial Results and Provides Corporate Update

08/08/2018 - 22:05

MENLO PARK, Calif., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases, today reported [...]